Strategic manufacturing partnership supports late-stage development of promising immunotherapy drug
Basel, 9 April 2026 – ImmuneOncia Therapeutics, a clinical-stage biopharmaceutical company, has partnered with Lonza, a global contract development and manufacturing organization, to support the late-stage clinical supply of its...
UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The event is set to spotlight the strength, global relevance, and collaborative spirit of the UK’s biotechnology...
Eli Lilly’s new oral GLP-1 drug promises easier access, simpler use, and a new future for obesity treatment
Washington, D.C., 2 April 2026 – In a breakthrough for obesity treatment, the US Food and Drug Administration has approved Foundayo (orforglipron),...
Switzerland’s pharmacy leader adapts to new rules and online trends while offering steady returns to global investors
Zurich, Switzerland, 26 March 2026 – Galenica AG, one of Switzerland’s leading pharmaceutical wholesalers and pharmacy operators, is navigating a period of change...
Strategic manufacturing partnership supports late-stage development of promising immunotherapy drug
Basel, 9 April 2026 – ImmuneOncia Therapeutics, a clinical-stage biopharmaceutical company, has partnered with Lonza, a global contract development and manufacturing organization, to support the late-stage clinical supply of its...
UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The event is set to spotlight the strength, global relevance, and collaborative spirit of the UK’s biotechnology...
Eli Lilly’s new oral GLP-1 drug promises easier access, simpler use, and a new future for obesity treatment
Washington, D.C., 2 April 2026 – In a breakthrough for obesity treatment, the US Food and Drug Administration has approved Foundayo (orforglipron),...
Switzerland’s pharmacy leader adapts to new rules and online trends while offering steady returns to global investors
Zurich, Switzerland, 26 March 2026 – Galenica AG, one of Switzerland’s leading pharmaceutical wholesalers and pharmacy operators, is navigating a period of change...
Strategic manufacturing partnership supports late-stage development of promising immunotherapy drug
Basel, 9 April 2026 – ImmuneOncia Therapeutics, a clinical-stage biopharmaceutical company, has partnered with Lonza, a global contract development and manufacturing organization, to support the late-stage clinical supply of its...
UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The event is set to spotlight the strength, global relevance, and collaborative spirit of the UK’s biotechnology...
Eli Lilly’s new oral GLP-1 drug promises easier access, simpler use, and a new future for obesity treatment
Washington, D.C., 2 April 2026 – In a breakthrough for obesity treatment, the US Food and Drug Administration has approved Foundayo (orforglipron),...
Switzerland’s pharmacy leader adapts to new rules and online trends while offering steady returns to global investors
Zurich, Switzerland, 26 March 2026 – Galenica AG, one of Switzerland’s leading pharmaceutical wholesalers and pharmacy operators, is navigating a period of change...
